Identification
CAS Number
1141892-29-6
Name
Sodium levofolinate
Synonyms
(2S)-2-{[4-({[(6S)-2-Amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydro-6-ptéridinyl]méthyl}amino)benzoyl]amino}pentanedioate de disodium [French] [ACD/IUPAC Name]
1141892-29-6 [RN]
Dinatrium-(2S)-2-{[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydro-6-pteridinyl]methyl}amino)benzoyl]amino}pentandioat [German] [ACD/IUPAC Name]
Disodium (2S)-2-{[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydro-6-pteridinyl]methyl}amino)benzoyl]amino}pentanedioate [ACD/IUPAC Name]
Disodium (2S)-2-{[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]amino}pentanedioate
LEVOLEUCOVORIN DISODIUM
L-Glutamic acid, N-[4-[[[(6S)-2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-, sodium salt (1:2) [ACD/Index Name]
163254-40-8 [RN]
Disodium folinate
LEUCOVORIN SODIUM
UNII-4MXU9LJS4Q
SMILES
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)nc([nH]3)N)N2C=O.[Na+].[Na+]
StdInChI
InChI=1S/C20H23N7O7.2Na/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);;/q;2*+1/p-2/t12-,13-;;/m0../s1
StdInChIKey
FSDMNNPYPVJNAT-NJHZPMQHSA-L
Molecular Formula
C20H21N7Na2O7
Molecular Weight
517.403
Properties
Appearance
White to yellow amorphous or crystalline
Safety Data
RIDADR
Not dangerous goods
WGK Germany
3
Specifications and Other Information of Our Sodium levofolinate CAS 1141892-29-6
Identification Methods
HNMR, HPLC
Purity
97% min
Assay(on anhydrous basis)
97.0-102.0%
Heavy Metals
≤50ppm
Water
≤17%
Related substances
Any other impurity
≤2.0%
Total Impurities
≤3.0%
D-lsorner
≤1.0%
Shelf Life
1 year
Storage
Under room temperature away from light
Known Application
It can be used as an antidote for folic acid antagonists (such as methotrexate, pyrimethamine or trimethoprim, etc.); it can also be used for the treatment of megaloblastic anemia caused by folate deficiency and the treatment of advanced colon and rectal cancer.